Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
5.02
+0.32 (6.81%)
At close: Oct 31, 2025, 4:00 PM EDT
4.987
-0.030 (-0.65%)
After-hours: Oct 31, 2025, 7:39 PM EDT
SONN Market Cap
SONN has a market cap or net worth of $34.27 million as of October 31, 2025. Its market cap has increased by 1,038.29% in one year.
Market Cap
34.27M
Enterprise Value
34.02M
1-Year Change
1,038.29%
Ranking
Category
Stock Price
$5.02
Market Cap Chart
Since April 2, 2020, SONN's market cap has decreased from $58.10M to $34.27M, a decrease of -41.01%. That is a compound annual growth rate of -9.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 32.43M | 638.58% |
| Dec 31, 2024 | 4.39M | -17.79% |
| Dec 29, 2023 | 5.34M | -41.46% |
| Dec 30, 2022 | 9.12M | -63.34% |
| Dec 31, 2021 | 24.89M | -35.01% |
| Dec 31, 2020 | 38.30M | -34.08% |
| Apr 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 761.97B |
| Johnson & Johnson | 454.87B |
| AbbVie | 388.18B |
| UnitedHealth Group | 312.28B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 215.90B |